Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > EPHA2(Gene name) > Human
  • Add your favorite
  • EPHA2 (Gene name),
  • Ephrin type-A receptor 2 (Protein name ),  EPHA2_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    EPHA2(ECK);
    Protein name:
    Ephrin type-A receptor 2;
    Alternative:
    Tyrosine-protein kinase receptor ECK;Epithelial cell kinase;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Homodimer. Interacts with SLA. Interacts (phosphorylated form) with VAV2, VAV3 and PI3-kinase p85 subunit (PIK3R1, PIK3R2 or PIK3R3); critical for the EFNA1-induced activation of RAC1 which stimulates cell migration. Interacts with ANKS1A (By similarity). Interacts with INPPL1; regulates activated EPHA2 endocytosis and degradation. Interacts (inactivated form) with PTK2 and interacts (EFNA1 ligand-activated form) with PTPN11; regulates integrin-mediated adhesion. Interacts with ARHGEF16, DOCK4 and ELMO2; mediates ligand-independent activation of RAC1 which stimulates cell migration. Interacts with CLDN4; phosphorylates CLDN4 and may regulate tight junctions. Interacts with ACP1.
    Function:
    Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate to UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis.
    Subcellular Location:
    Cell membrane Single-pass type I membrane protein Cell projection ruffle membrane Single-pass type I membrane protein Cell projection lamellipodium membrane Single-pass type I membrane protein Cell junction focal adhesion Present at regions of cell-cell contacts but also at the leading edge of migrating cells.
    Protein Attributes:
    Sequence length:
    976
    Sequence:
    50:
    MELQAARACF | ALLWGCALAA | AAAAQGKEVV | LLDFAAAGGE | LGWLTHPYGK | 
    100:
    GWDLMQNIMN | DMPIYMYSVC | NVMSGDQDNW | LRTNWVYRGE | AERIFIELKF | 
    150:
    TVRDCNSFPG | GASSCKETFN | LYYAESDLDY | GTNFQKRLFT | KIDTIAPDEI | 
    200:
    TVSSDFEARH | VKLNVEERSV | GPLTRKGFYL | AFQDIGACVA | LLSVRVYYKK | 
    250:
    CPELLQGLAH | FPETIAGSDA | PSLATVAGTC | VDHAVVPPGG | EEPRMHCAVD | 
    300:
    GEWLVPIGQC | LCQAGYEKVE | DACQACSPGF | FKFEASESPC | LECPEHTLPS | 
    350:
    PEGATSCECE | EGFFRAPQDP | ASMPCTRPPS | APHYLTAVGM | GAKVELRWTP | 
    400:
    PQDSGGREDI | VYSVTCEQCW | PESGECGPCE | ASVRYSEPPH | GLTRTSVTVS | 
    450:
    DLEPHMNYTF | TVEARNGVSG | LVTSRSFRTA | SVSINQTEPP | KVRLEGRSTT | 
    500:
    SLSVSWSIPP | PQQSRVWKYE | VTYRKKGDSN | SYNVRRTEGF | SVTLDDLAPD | 
    550:
    TTYLVQVQAL | TQEGQGAGSK | VHEFQTLSPE | GSGNLAVIGG | VAVGVVLLLV | 
    600:
    LAGVGFFIHR | RRKNQRARQS | PEDVYFSKSE | QLKPLKTYVD | PHTYEDPNQA | 
    650:
    VLKFTTEIHP | SCVTRQKVIG | AGEFGEVYKG | MLKTSSGKKE | VPVAIKTLKA | 
    700:
    GYTEKQRVDF | LGEAGIMGQF | SHHNIIRLEG | VISKYKPMMI | ITEYMENGAL | 
    750:
    DKFLREKDGE | FSVLQLVGML | RGIAAGMKYL | ANMNYVHRDL | AARNILVNSN | 
    800:
    LVCKVSDFGL | SRVLEDDPEA | TYTTSGGKIP | IRWTAPEAIS | YRKFTSASDV | 
    850:
    WSFGIVMWEV | MTYGERPYWE | LSNHEVMKAI | NDGFRLPTPM | DCPSAIYQLM | 
    900:
    MQCWQQERAR | RPKFADIVSI | LDKLIRAPDS | LKTLADFDPR | VSIRLPSTSG | 
    950:
    SEGVPFRTVS | EWLESIKMQQ | YTEHFMAAGY | TAIEKVVQMT | NDDIKRIGVR | 
    976:
    LPGHQKRIAY | SLLGLKDQVN | TVGIPI
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    MIM:
    KEGG:
    Pfam:
    SMR:
    Pfam:
    UniGene:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human Ephrin type-A receptor 2
    ELISA Kit for Human Ephrin type-A receptor 2
    CLIA Kit for Human Ephrin type-A receptor 2
    CLIA Kit for Human Ephrin type-A receptor 2
    Polyclonal Antibody for Human Ephrin type-A receptor 2
    Polyclonal Antibody for Human Ephrin type-A receptor 2
    Monoclonal Antibody for Human Ephrin type-A receptor 2
    Monoclonal Antibody for Human Ephrin type-A receptor 2
    Protein for Human Ephrin type-A receptor 2
    Protein for Human Ephrin type-A receptor 2

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases."
      Lindberg R.A. , Hunter T.
      Mol. Cell. Biol.10:6316-6324(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);CATALYTIC ACTIVITY;AUTOPHOSPHORYLATION
      tissue: Epithelium.
    2. 2.
      "Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis."
      Jin P. , Zhang J. , Sumariwalla P.F. , Ni I. , Jorgensen B. , Crawford D. , Phillips S. , Feldmann M. , Shepard H.M. , Paleolog E.M.
      Arthritis Res. Ther.10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2);ALTERNATIVE SPLICING
    3. 3.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    4. 4.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    5. 5.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
      tissue: Pancreas.
    6. 6.
      "Unified nomenclature for Eph family receptors and their ligands, the ephrins."
      Eph nomenclature committee
      Cell90:403-404(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NOMENCLATURE
    7. 7.
      "Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation."
      Miao H. , Burnett E. , Kinch M. , Simon E. , Wang B.
      Nat. Cell Biol.2:62-69(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN INTEGRIN-MEDIATED CELL ADHESION;FUNCTION IN CELL MIGRATION;PHOSPHORYLATION;INTERACTION WITH PTK2/FAK1 AND PTPN11;SUBCELLULAR LOCATION
    8. 8.
      "EphA2 overexpression causes tumorigenesis of mammary epithelial cells."
      Zelinski D.P. , Zantek N.D. , Stewart J.C. , Irizarry A.R. , Kinch M.S.
      Cancer Res.61:2301-2306(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ONCOGENICITY
    9. 9.
      "Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation."
      Kikawa K.D. , Vidale D.R. , Van Etten R.L. , Kinch M.S.
      J. Biol. Chem.277:39274-39279(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH ACP1;DEPHOSPHORYLATION BY ACP1
    10. 10.
      "EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability."
      Tanaka M. , Kamata R. , Sakai R.
      J. Biol. Chem.280:42375-42382(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELL-CELL INTERACTION;INTERACTION WITH CLDN4;MUTAGENESIS OF LYS-646
    11. 11.
      "Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK."
      Liu D.-P. , Wang Y. , Koeffler H.P. , Xie D.
      Int. J. Oncol.30:865-871(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: TISSUE SPECIFICITY
    12. 12.
      "Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation."
      Zhuang G. , Hunter S. , Hwang Y. , Chen J.
      J. Biol. Chem.282:2683-2694(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH INPPL1
    13. 13.
      "EphA2 is an essential mediator of UV radiation-induced apoptosis."
      Zhang G. , Njauw C.-N. , Park J.M. , Naruse C. , Asano M. , Tsao H.
      Cancer Res.68:1691-1696(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN APOPTOSIS;INDUCTION BY UV
    14. 14.
      "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
      Daub H. , Olsen J.V. , Bairlein M. , Gnad F. , Oppermann F.S. , Korner R. , Greff Z. , Keri G. , Stemmann O. , Mann M.
      Mol. Cell31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570; SER-579 AND THR-647;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    15. 15.
      "Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor."
      Wykosky J. , Palma E. , Gibo D.M. , Ringler S. , Turner C.P. , Debinski W.
      Oncogene27:7260-7273(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION;PHOSPHORYLATION
    16. 16.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570; SER-892 AND SER-901;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    17. 17.
      "EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt."
      Miao H. , Li D.Q. , Mukherjee A. , Guo H. , Petty A. , Cutter J. , Basilion J.P. , Sedor J. , Wu J. , Danielpour D. , Sloan A.E. , Cohen M.L. , Wang B.
      Cancer Cell16:9-20(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: DISEASE;FUNCTION IN CELL MIGRATION;SUBCELLULAR LOCATION;MUTAGENESIS OF ASP-739 AND SER-897;PHOSPHORYLATION AT SER-897 BY PKB
    18. 18.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-435
      tissue: Liver.
    19. 19.
      "Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis."
      Annamalai B. , Liu X. , Gopal U. , Isaacs J.S.
      Mol. Cancer Res.7:1021-1032(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: UBIQUITINATION BY STUB1
    20. 20.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570; TYR-628; THR-647 AND SER-869;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    21. 21.
      "Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism."
      Hiramoto-Yamaki N. , Takeuchi S. , Ueda S. , Harada K. , Fujimoto S. , Negishi M. , Katoh H.
      J. Cell Biol.190:461-477(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELL MIGRATION;INTERACTION WITH ARHGEF16; DOCK4 AND ELMO2
    22. 22.
      "Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1."
      Lin S. , Gordon K. , Kaplan N. , Getsios S.
      Mol. Biol. Cell21:3902-3914(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN KERATINOCYTE ADHESION AND DIFFERENTIATION;SUBCELLULAR LOCATION
    23. 23.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    24. 24.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    25. 25.
      "Solution structure of the first Sam domain of Odin and binding studies with the EphA2 receptor."
      Mercurio F.A. , Marasco D. , Pirone L. , Pedone E.M. , Pellecchia M. , Leone M.
      Biochemistry51:2136-2145(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH ANKS1A
    26. 26.
      "The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma-associated herpesvirus."
      Hahn A.S. , Kaufmann J.K. , Wies E. , Naschberger E. , Panteleev-Ivlev J. , Schmidt K. , Holzer A. , Schmidt M. , Chen J. , Konig S. , Ensser A. , Myoung J. , Brockmeyer N.H. , Sturzl M. , Fleckenstein B. , Neipel F.
      Nat. Med.18:961-966(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH HHV-8 GLYCOPROTEIN L/GLYCOPROTEIN H
    27. 27.
      "Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migration."
      Lee H. , Bennett A.M.
      Mol. Cell. Biol.33:1430-1441(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELL MIGRATION;PHOSPHORYLATION AT TYR-930;DEPHOSPHORYLATION AT TYR-930 BY PTPRF;INTERACTION WITH NCK1
    28. 28.
      "Early insights into the function of KIAA1199, a markedly overexpressed protein in human colorectal tumors."
      Tiwari A. , Schneider M. , Fiorino A. , Haider R. , Okoniewski M.J. , Roschitzki B. , Uzozie A. , Menigatti M. , Jiricny J. , Marra G.
      PLoS ONE8:E69473-E69473(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH CEMIP
    29. 29.
      "Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography."
      Nowakowski J. , Cronin C.N. , McRee D.E. , Knuth M.W. , Nelson C.G. , Pavletich N.P. , Rogers J. , Sang B.C. , Scheibe D.N. , Swanson R.V. , Thompson D.A.
      Structure10:1659-1667(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 596-900
    30. 30.
      "Solution structure of the C-terminal SAM-domain of EPHAA2: ephrin type-A receptor 2 precursor (EC 2.7.10.1)."
      RIKEN structural genomics initiative (RSGI)
      Submitted (2008-01) to the PDB data bank
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 902-976
    31. 31.
      "Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex."
      Himanen J.P. , Goldgur Y. , Miao H. , Myshkin E. , Guo H. , Buck M. , Nguyen M. , Rajashankar K.R. , Wang B. , Nikolov D.B.
      EMBO Rep.10:722-728(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.52 ANGSTROMS) OF 28-201;X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 28-201 IN COMPLEX WITH EFNA1;SUBUNIT;DISULFIDE BOND;MUTAGENESIS OF ARG-103
    32. 32.
      "Ephrin A1 bound to the ligand binding domain of the human ephrin A2 (EPHA2) receptor protein kinase."
      Structural genomics consortium (SGC)
      Submitted (2009-02) to the PDB data bank
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 25-202;DISULFIDE BOND
    33. 33.
      "Left-handed dimer of EPHA2 transmembrane domain helix packing diversity among receptor tyrosine kinases."
      Mayzel M.L. , Bocharov E.V. , Volynsky P.E. , Arseniev A.S.
      Submitted (2009-08) to the PDB data bank
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 523-563
    34. 34.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 23-202 IN COMPLEX WITH EFNA1;SUBUNIT
    35. 36.
      "The EPHA2 gene is associated with cataracts linked to chromosome 1p."
      Shiels A. , Bennett T.M. , Knopf H.L.S. , Maraini G. , Li A. , Jiao X. , Hejtmancik J.F.
      Mol. Vis.14:2042-2055(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CTRCT6 TRP-948
    36. 37.
      "Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract."
      Zhang T. , Hua R. , Xiao W. , Burdon K.P. , Bhattacharya S.S. , Craig J.E. , Shang D. , Zhao X. , Mackey D.A. , Moore A.T. , Luo Y. , Zhang J. , Zhang X.
      Hum. Mutat.30:E603-E611(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CTRCT6 ILE-940
    37. 38.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CTRCT6 GLN-721;CHARACTERIZATION OF VARIANT CTRCT6 GLN-721
    38. 39.
      "Human cataract mutations in EPHA2 SAM domain alter receptor stability and function."
      Park J.E. , Son A.I. , Hua R. , Wang L. , Zhang X. , Zhou R.
      PLoS ONE7:E36564-E36564(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION OF VARIANTS CTRCT6 ILE-940 AND CTRCT6 TRP-948
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2026 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter